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Abstract
The hippocampus, a brain area critical for learning and memory, is especially vulnerable to damage at early stages
of Alzheimer’s disease (AD). Emerging evidence has indicated that altered neurogenesis in the adult hippocampus
represents an early critical event in the course of AD. Although causal links have not been established, a variety of
key molecules involved in AD pathogenesis have been shown to impact new neuron generation, either positively
or negatively. From a functional point of view, hippocampal neurogenesis plays an important role in structural
plasticity and network maintenance. Therefore, dysfunctional neurogenesis resulting from early subtle disease
manifestations may in turn exacerbate neuronal vulnerability to AD and contribute to memory impairment,
whereas enhanced neurogenesis may be a compensatory response and represent an endogenous brain repair
mechanism. Here we review recent findings on alterations of neurogenesis associated with pathogenesis of AD,
and we discuss the potential of neurogenesis-based diagnostics and therapeutic strategies for AD.
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Introduction
Alzheimer’s disease (AD), first described by the German
neuropathologist Alois Alzheimer as Dementia Praecox
in 1907, is an age-related neurodegenerative disease
characterized by progressive loss of memory and dete-
rioration of cognitive functions. Individuals with the dis-
order usually experience difficulties in learning,
performance speed, recall accuracy and/or problem sol-
ving [1]. The gradual intraneuronal accumulation of
neurofibrillary tangles formed as a result of abnormal
hyperphosphorylation of cytoskeletal tau protein, extra-
cellular deposition of amyloid-b (Ab) protein as senile
plaques, and massive neuronal death represent impor-
tant neuropathological hallmarks of AD [2]. These
pathologies are evident in specific, vulnerable brain
areas and the hippocampus is one of the earliest to be
affected [3]. The hippocampus is a mammalian brain
structure that lies under the medial temporal lobe, with
one on each side of the brain. Although there is a lack
of consensus relating to terms describing the hippocam-
pus and its adjacent cortex, the term hippocampus or
hippocampal formation generally applies to the dentate
gyrus (DG), the hippocampus proper - composed of
CA1, CA2 and CA3 fields - and the subiculum. The
organization of the hippocampal circuitry has been tra-
ditionally characterized as a unidirectional, trisynaptic
excitatory pathway (reviewed in [4]). Briefly, the entorh-
inal cortex (EC) provides the main source of input to
the hippocampus through connections to the DG. Infor-
mation flow then proceeds from DG to CA3 to CA1. In
turn, CA1 projects to the subiculum and sends the hip-
pocampal output back to the deep layers of EC. Beha-
vioral studies have long suggested that the hippocampus
plays a critical role in learning and memory [5], which
depend on functional and structural changes occurring
in the hippocampus, such as long-term potentiation
(LTP) and synaptic remodeling [6,7]. The discovery of a
de novo production of neurons in the adult DG has
introduced the possibility of a new form of plasticity
that could sustain memory processes. A growing body
of evidence supports the view that promotion of adult
hippocampal neurogenesis improves pattern separation
and spatial memory [8,9]. In contrast, a decline in neu-
rogenesis may underlie cognitive impairments associated
with aging and disorders such as AD [10,11]. Interest-
ingly, increasing evidence shows that central molecular
players in AD influence the generation of new
* Correspondence: ymu@salk.edu
Laboratory of Genetics, the Salk Institute for Biological Studies, La Jolla, CA
92037, USA
Mu and Gage Molecular Neurodegeneration 2011, 6:85
http://www.molecularneurodegeneration.com/content/6/1/85
© 2011 Mu and Gage; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.hippocampal neurons, and noteworthy alterations in
neurogenesis take place earlier than the onset of hall-
mark lesions or neuronal loss [12]. Although seemingly
contradictory results have been reported in both murine
and human studies [13], preserving or potentiating the
production of new neurons has been regarded as a
potential therapeutic strategy to delay or halt AD-linked
cognitive decline. Furthermore, understanding the
mechanisms of changes in neurogenesis observed at
initial and later stages of AD will contribute to the
development of early AD biomarkers and reveal insights
into the pathogenesis of AD. In this manuscript, we will
summarize current knowledge of the neurogenic roles of
molecules whose mutations cause AD, and we will dis-
cuss the potential application of newly generated hippo-
campal neurons in the diagnosis and treatment of AD.
Neurogenesis in the adult hippocampus
Continual production of new neurons in the adult hip-
pocampus was first reported by Altman and colleagues
[14]. These new neurons originate from self-renewing
and multipotent adult neural stem cells (NSCs) residing
in the subgranular zone (SGZ) of DG [15]. Two types of
NSCs have been identified based on their specific
morphologies, proliferative behaviors and expression of
unique sets of molecular markers (reviewed in [16]).
Type 1 neural progenitor cells (NPCs) have a radial pro-
cess spanning the entire granule cell layer and ramifying
in the inner molecular layer of DG. They are generally
identified by specific molecular markers such as GFAP,
Sox2 and Nestin. These cells have been hypothesized to
be the quiescent stem cells that generate the second
type of NSC, the actively self-amplifying, nonradial type
2 cells. These intermediate cells, expressing Sox2, Nestin
b u tn o tG F A P ,s u b s e q u e n t l yg i v er i s et oD C X +n e u r o -
blasts that differentiate into glutamatergic dentate gran-
ule cells (DGCs) populating the inner third of the
granule cell layer. Young adult rats generate approxi-
mately 9,000 new cells in the SGZ each day, with a sur-
vival rate of ~50% [17]. The surviving cells send
dendrites to the molecular layer of DG to receive inputs
from the EC and send axonal projections to the CA3
subfield of the hippocampus to innervate hilar inter-
neurons, mossy cells and CA3 pyramidal cells (Figure
1), thereby integrating into existing neuronal circuits
[18,19]. The process of new neuron generation and
incorporation involves multiple crucial steps. Many
layers of regulation, composed of both intrinsic and
Figure 1 Neurogenesis in the adult hippocampus. A population of radial cells in the SGZ corresponds to quiescent NSCs (type 1 cells). They
coexist with actively proliferating nonradial NSCs (type 2 cells) that generate both astrocytes and neuroblasts. Neuroblasts migrate into the
granule cell layer (GCL) and differentiate into dentate granule cells (DGCs). Newborn DGCs gradually develop elaborate dendritic trees in the
molecular layer (Mol) to receive inputs from the EC and project to CA3 pyramidal neurons (red) as well as hilar interneurons (blue).
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For example, a number of morphogens that are critical
during embryonic development of the nervous system,
including Notch, Shh, Wnts, and BMPs, are conserved
and continue to serve as niche signals to regulate main-
tenance, activation, and fate choice of adult NSCs. Var-
ious neurotransmitter systems, growth factors,
neurotrophins, cytokines, and hormones are also major
regulators of different phases of adult neurogenesis.
Additionally, intrinsic factors such as miRNAs, tran-
scription factors, cell-cycle regulators, and epigenetic
factors exhibit cell-autonomous characteristics that pro-
vide adult NSCs with the potential to proliferate, differ-
entiate, and survive as newborn neurons.
Comprehensive reviews on this subject can be found
elsewhere [16,20].
During maturation, newly formed DGCs differ sub-
stantially from their older, neighboring counterparts in
terms of electrophysiological properties. Typically, they
exhibit enhanced synaptic plasticity with both increased
amplitude and decreased induction threshold for LTP
[21-24]. While the precise functional implications of the
continuous production of new neurons with hyperexcit-
ability and enhanced synaptic plasticity are still under
intense investigation, it has become increasingly appar-
e n tt h a tn e u r o g e n e s i si nt h ea d u l tD Gc o n t r i b u t e st o
various types of hippocampus-dependent learning and
memory. The first definitivee v i d e n c ew a sp r o v i d e db y
the demonstration that a substantial reduction in the
number of newly generated DGCs by an antimitotic
agent MAM disrupted trace eye-blink conditioning and
trace fear conditioning, both of which are regarded to
be hippocampus-dependent [25]. A number of subse-
quent studies utilizing irradiation or genetic modifica-
tion to eliminate adult neurogenesis in rodent models
also observed impaired performance in spatial-naviga-
tion learning and long-term spatial memory retention,
spatial pattern discrimination, trace conditioning and
contextual fear conditioning, clearance of hippocampal
memory traces, and reorganization of memory to extra-
hippocampal substrates (reviewed in [26,27]). Conver-
sely, genetic manipulation and deep brain stimulation
that boost neurogenesis have been shown to facilitate
pattern separation and water-maze memory, respectively
[8,9]. With a combination of theoretical and experimen-
tal approaches at cellular, network and system levels,
future studies will clarify how addition of a relatively
small number of new neurons can modulate global hip-
pocampal or brain function.
Neurogenesis deficits in AD mouse models
As described in the introduction, senile plaques, a neu-
ropathological hallmark of AD, are made up largely of
38-43 amino acid b-amyloid peptides (Ab), which are
liberated from a larger integral membrane protein, amy-
loid precursor protein (APP), by sequential b-a n dg-
secretase cleavage [2]. Several lines of evidence support
the hypothesis that Ab is a key trigger of AD pathogen-
esis [28]. The vast majority of AD cases appear in late-
o n s e ts p o r a d i cf o r m .W h i l ea g i n gi st h eg r e a t e s te n v i r -
onmental risk factor of the sporadic form, the presence
of the ε 4 allele in apolipoprotein E (ApoE4) represents
the most important genetic risk factor [29]. Rare, famil-
ial, early-onset autosomal dominant forms of AD (FAD)
are found to involve mutations in the genes encoding
APP and presenilins (PS1 and PS2). Presenilins form the
catalytic core of the aspartyl protease g-secretase com-
plex responsible for intramembranous processing of a
variety of type I membrane proteins, including APP.
Cleavage of APP at the N-terminus by b-secretase and
at the C-terminus by the g-secretase complex constitutes
the amyloidogenic pathway, which yields the APP intra-
cellular domain (AICD) fragment in addition to Ab.I n
the non-amyloidogenic pathway, a-secretase cleaves
APP within the Ab domain, which results in generation
of a soluble fragment of APP (sAPPa) and a membrane-
bound carboxyl-terminal fragment, thereby precluding
the formation of Ab ( F i g u r e2 ) .S t r i k i n g l y ,q u i t eaf e w
molecules central to AD have been found to play a reg-
ulatory role in aspects of adult neurogenesis. Using a
loss-of-function animal model by crossing ApoE-defi-
cient mice to a nestin-GFP reporter, Yang et al. demon-
strated that lack of ApoE increased proliferation of early
NPCs within the DG, which resulted in depletion of the
overall pool of Type 1 NPCs over time [30]. A recent
study showed that NPCs infected with lentiviral vectors
expressing short interfering RNA (siRNA) for the exclu-
sive knockdown of PS1 in the neurogenic microenviron-
ments exhibited a dramatic enhancement of cell
differentiation in a g-secretase-dependent manner [31].
BrdU incorporation assay has shown that AICD expres-
sion decreased hippocampal progenitor cell proliferation
and survival [32]. In contrast to the negative effect of
AICD on neurogenesis, the sAPPa was shown to protect
neurons and promote neurogenesis, possibly mediated
by its ability to prevent overactivation of CDK5 and tau
hyperphosphorylation [33]. For instance, sAPPa regu-
lated proliferation of EGF-responsive NPCs in the sub-
ventricular zone (SVZ) of the lateral ventricle, the other
neurogenic area of the adult brain [34]. Although it was
suggested that the effect of sAPPa was limited in the
S V Z ,d u et ot h ea b s e n c eo fs A P P a-binding sites in the
SGZ [34], this conclusion contrasts with the observation
that deficiency of the sortilin-related receptor with type-
A repeats resulted in increased proliferation and survival
of NPCs in both the SVZ and the DG, most likely as a
consequence of an enhancement of local sAPPa produc-
tion [35]. Information from studies using gene-modified
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1). Mutations of PS1 generally have a negative effect on
the production of new neurons, although the depen-
dency of g-secretase remains to be confirmed. Using
PS1M146V knock-in mice in which the M146V muta-
tion is incorporated into the endogenous mouse PS1
gene, Wang et al. reported that the FAD mutation
impaired contextual fear conditioning, which is corre-
lated with reduced adult neurogenesis in the DG [36].
Expression of human mutant PS1P117L in transgenic
mice decreased the survival of BrdU-labeled NPCs,
thereby leading to fewer new b-III-tubulin-
immunoreactive neurons being generated in FAD
mutant animals during the 4-week postlabeling period
[37]. Enriched environment (EE)-induced proliferation
and neuronal differentiation of hippocampal progenitor
cells in mice harboring transgenes encoding the FAD-
linked human PS1 variant PS1ΔE9 or PS1M146L were
significantly impaired, although the impairment was at
least in part mediated by soluble factors released from
microglia, thus indicating a non-cell-autonomous
mechanism underlying PS1 regulation of adult hippo-
campal neurogenesis [38]. Similarly, the proliferation
and survival of NPC were reduced in transgenic mice
Figure 2 Molecular basis for AD and interaction with neurogenesis in the adult hippocampus. In the non-amyloidogenic pathway, APP is
processed by a-secretase that cleaves within the Ab domain. sAPPa and a membrane-bound carboxyl-terminal fragment are generated. In the
amyloidogenic pathway, APP is sequentially cleaved by b- and g-secretases to release the neurotoxic Ab peptide. b-secretase cleavage of APP
forms a secreted ectodomain sAPPb and a membrane-bound fragment. Cleavage of the latter product generates AICD and Ab. Suggested
functions of relevant signal molecules in adult hippocampal neurogenesis are summarized.
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695swe (APPswe) polypeptide, a mutated form of APP
that causes early onset FAD [39]. An age-dependent
decrease in SGZ proliferation was also observed in mice
transgenic for human V717F mutant APP, a model of
AD with age-dependent accumulation of Ab42-contain-
ing plaques [40]. Furthermore, adult neurogenesis was
reduced in mice with knock-out (KO) for ApoE or with
knock-in (KI) alleles for human ApoE4. Increased BMP
signaling promoted glial differentiation at the expense of
neurogenesis in ApoE-KO mice, whereas presynaptic
GABAergic input-mediated maturation of newborn neu-
rons was diminished in ApoE4-KI mice because of
decreased interneuron survival. Potentiating GABAergic
signaling restored neuronal maturation and neurogenesis
in ApoE4-KI mice to normal levels [41]. Several
additional studies examined hippocampal neurogenesis
in transgenic mice coexpressing two or three mutated
genes. For example, the double knock-in mice harboring
mutant APPswe/PS1ΔE9 exhibited a significant reduc-
tion in dentate neuroblasts [42]. Long-term survival of
newborn neurons was dramatically diminished in trans-
g e n i cm i c eo v e r e x p r e s s i n gt h eS w e d i s hv a r i a n to fA P P
and the exon 9-deleted variant of human PS1 [43]. In
particular, a significant reduction in proliferation of
NPCs and neuronal differentiation was found to take
place in the same transgenic mouse line long before
amyloid deposition, and interestingly, hyperphosphoryla-
tion of the microtubule-associated protein tau in the
neurogenic niches might underlie the impaired neuro-
genesis [44]. Another study was performed in the triple
transgenic mice 3xTg-AD that harbors three mutant
Table 1 Summary of neurogenesis changes in transgenic mouse models of AD
Genetic
Manipulation
Strain
Name
Genotype Promoter Age
(mon)
Pathology
(Ab
deposition)
Neurogenesis
assessment
Effect Reference
Knock-in mo
PS1M146V/-
3 BrdU injection twice
daily (2 hr apart) for 4
consecutive days
Decreased proliferation and
differentiation
[36]
hu ApoE4 3, 6-7,
12-13
BrdU injection twice (6
hr apart)
Diminished neuronal maturation [41]
mo APPswe/
PS1ΔE9
8-9
18-24
post DCX, MCM2
immunostaining
Decreased proliferation [42]
Transgenic hu PS1P117L NSE 3-4 one BrdU injection per
day for 12 consecutive
days
Decreased survival [37]
hu PS1ΔE9,
hu PS1M146L
PrP 3 single injection of
BrdU
Decreased proliferation and
differentiation
[38]
Tg2576 chimeric mo-
hu APPswe
PrP 12-14 pre five daily injections of
BrdU
Decreased proliferation, survival and
differentiation
[39]
PDAPP hu APPind PDGF 2
12
pre
post
one i.p. injection of
BrdU
Decreased proliferation and survival [40]
APP/
PS1
chimeric mo-
hu APPswe/
hu PS1ΔE9
PrP 6 pre, post BrdU injection once
daily for 12
consecutive days
Decreased survival [43]
APP/
PS1
chimeric mo-
hu APPswe/
hu PS1ΔE9
PrP 2 pre BrdU injection every
12 hr for 3 days
Decreased proliferation and
differentiation
[44]
3xTg-
AD
hu APPswe/
PS1M146V/
tauP301L
Thy-1.2 4, 9 Decreased proliferation [45]
J20 hu APPswe,
ind
PDGF 3, 12 pre, post BrdU injection twice
daily (8 hr apart) for 3
consecutive days
Increased proliferation and
differentiation
[46]
J20 hu APPswe,
ind
PDGF 3, 5,
9, 11
pre, post daily injection of BrdU
for 5 days
Increased proliferation and
differentiation
[47]
J20 hu APPswe,
ind
PDGF 2-3 pre BrdU injection for 3
days
Accelarated early development but
impaired late maturation of newborn
neurons
[48]
Knock-out ApoE 3, 6-7,
12-13
BrdU injection twice (6
hr apart)
Reduced neurogenesis but increased
astrogenesis
[41]
PS1/PS2
forebrain KO
7-9
18-20
single dose injection
of BrdU
Enhanced cell proliferation at early
stages of neurodegeneration but
impaired survival at late stages
[49]
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proliferation was found in 3xTg-AD mice; this reduction
was directly associated with the presence of Ab plaques
and an increase in the number of Ab-containing neu-
rons in the hippocampus [45]. Despite this compelling
evidence for a generalized decrease in new neuron gen-
eration in AD mouse models, conflicting observations
have been reported. PDGF-APPswe, ind mice (J20),
which express the Swedish and Indiana APP mutations
driven by a PDGF promoter, showed increased incor-
poration of BrdU and expression of immature neuronal
markers in the DG. These changes occurred before neu-
ronal loss and amyloid deposition could be detected
[46]. A separate study revealed an increase in not only
NSC proliferation but also neuronal differentiation in
J20 mice, which were induced by oligomeric Ab [47].
Additionally, adult-born DGCs in a similar animal
model exhibited longer dendrites, higher spine density
and stronger functional responses at an early develop-
mental stage, but they were impaired morphologically
and functionally during later maturation. Early inhibi-
tion of GABAergic signaling or late facilitation of gluta-
matergic signaling can normalize neuronal development
despite the presence of high Ab levels, suggesting that
abnormal GABAergic neurotransmission or an imbal-
ance between GABAergic and glutamatergic neurotrans-
mission may contribute to impaired neurogenesis in AD
models [48]. Notably, although most studies, as
described above, have demonstrated either a single com-
promise or a single enhancement of adult neurogenesis
resulting from AD-associated gene mutations, condi-
tional ablation of PS1 in the forebrain and knock out of
PS2 in adult mice (PS1/PS2 conditional double knock-
out) was found to cause neurodegenerative stage-depen-
dent dynamic changes. Cell proliferation was
significantly enhanced at early stages of neurodegenera-
tion, whereas the survival of newly generated neurons
was impaired up to late stages [49].
In summary, studies using transgenic models of AD
over the past few years have generated mounting evi-
dence supporting alterations in neurogenesis. Because of
differences in many parameters, there are apparent dis-
crepancies in the current literature, with a majority of
studies reporting compromised neurogenesis and some
others observing increased new neuron generation.
Thus, a systematic comparison of transgenic mice using
the same age, gender, genetic background, neuropathol-
ogy stage and a similar methodo fn e u r o g e n i ca n a l y s i s
(BrdU regimen, cell markers, etc.) would be necessary to
draw a definite conclusion. In particular, as promoters
determine the expression and neuronal populations of
the transgenes, transgenic lines are likely to express dis-
tinct levels and/or patterns of AD-associated proteins.
Therefore, investigation of different AD transgenic
models under the same promoter will be required as
well and knock-in lines are more relevant in this regard.
A thorough understanding of the molecular mechanisms
underlying changes in neurogenesis associated with
mutations of AD-causing genes will probably be a cru-
cial next step in understanding how they are linked to
the general intrinsic and extrinsic factors that have been
identified to regulate neurogenesis. In addition, although
numerous studies employing diverse paradigms suggest
that FAD-linked transgenic mice exhibit impairment in
learning and memory (see [50] for a review), it remains
unclear whether the malfunction results from decreased
hippocampal neurogenesis. In PS1M146V/- mice,
impaired contextual fear learning showed correlation
with reduced neurogenesis in the DG, whereas both
short-term and long-term synaptic plasticity in area
CA1 and DG remained unaffected [36]. This observation
has provided thus far the only piece of evidence directly
supporting the hypothesis that impaired adult neurogen-
esis exacerbates memory deficits. Nevertheless, the func-
tional implications of aberrant neurogenesis in
transgenic models of AD need to be further character-
ized to establish the causal relationship.
The existing transgenic animal models only exhibit
partial AD pathology and it is thus necessary to corre-
late the mouse model studies with human samples. One
study that analyzed neurogenesis in postmortem human
brains by Western blot and immunohistochemistry
methods reported that the hippocampus of senile AD
patients showed increased expression of immature neu-
ronal marker proteins that signal the birth of new neu-
rons, including DCX, polysialylated nerve cell adhesion
molecule, neurogenic differentiation factor and TUC-4.
The authors hypothesized that facilitation of neurogen-
esis might be a self-compensating mechanism to replace
the lost neurons and that stimulating hippocampal neu-
rogenesis might provide a new treatment strategy for
AD [51]. However, immunostaining for Ki-67, GFAP
and DCX in presenile AD cases revealed no indications
of altered DG neurogenesis [52]. Moreover, Ab-asso-
ciated increases in BMP6 expression were found accom-
panied by reduced markers of neurogenesis in the
hippocampus of human patients with AD [53].
Obviously, these findings are not in agreement, and the
discrepancies may arise from stage of the disease, treat-
ment provided to the patients and method for labeling
proliferating cells. More systematic studies are required
for further clarification.
Environmental Enrichment, Neurogenesis and AD
It has become increasingly evident that neurogenesis in
the adult brain is under the influence of key molecules
underlying AD and the alterations take place early in
life. Thus, the process of new neuron addition may have
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than be simply a result of neural dysfunction, a possibi-
lity that opens new opportunities for cellular therapy for
this disease. Physical exercise or exposure to EE, a puta-
tive positive regulator of adult neurogenesis [11],
improves cognitive performance in transgenic mouse
models of AD [54-56]. Complex environmental experi-
ence has been reported to reduce Ab levels and amyloid
deposition, rescue impaired neurogenesis, and signifi-
cantly enhance hippocampal LTP in APPswe/PS1DE9
mice [57,58]. Both running and EE increase the number
o fn e w b o r ng r a n u l ec e l l si nt h eD Go fA P P 2 3m i c ea n d
improve their water maze performance [59,60]. How-
ever, EE does not enhance neurogenesis in transgenic
mice harboring FAD-linked PS1 variants [38] or in fore-
brain-specific PS1 knockout mice [61], and it even sup-
presses neurogenesis in ApoE4 transgenic mice [62].
Taken together, these studies indicate that the effects of
exercise and EE on adult neurogenesis vary between the
mouse models of AD. Future experiments should inves-
tigate their impact on transgenic mice exhibiting differ-
ent aspects of AD pathology and determine the
dependence of observed behavioral improvement on res-
cued neurogenesis.
Conclusions
We have presented evidence that multiple molecular
players known to contribute to AD pathogenesis, mainly
ApoE, PS1, APP and its metabolites, can modulate adult
hippocampal neurogenesis. The apparent discrepancies
between increased and decreased new neuron produc-
tion in studies on human and transgenic murine models
m i g h tb er e c o n c i l e db yat h o r o ugh investigation of dif-
ferent NSC populations under different disease condi-
tions. Notably, alterations in neurogenesis occur at the
very early stage of AD progression, prior to processes
that may secondarily affect neurogenesis, such as neuro-
nal loss, amyloid deposition and inflammation. These
findings suggest that neurogenesis represents an integral
part of AD pathology. On the one hand, expression of
AD-causing molecules impinges upon neurogenesis and
dysregulated neurogenesis might in turn facilitate dis-
ease progression. On the other hand, conditions that sti-
mulate endogenous neurogenesis (e.g., environmental
stimuli, physical activity, trophic factors, cytokines, and
drugs) may help to promote the regenerative and recov-
ery process. Although newly generated DGCs are very
small in number as compared to the degenerating neu-
rons in AD, and therefore unlikely to achieve global
repair, it is possible to slow down or prevent severe cog-
nitive decline by eliminating initial deleterious triggers.
Furthermore, as compared to classical neuropathological
h a l l m a r k so fA D ,a d u l tn e u r o g e n e s i sm a ys e r v ea sa n
early-stage disease model for drug testing and screening.
The development of noninvasive detection of adult neu-
rogenesis and specific biomarkers might provide new
means of early diagnosis of AD.
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